Latest News
QV Named Regional Winners Superconnect 2021
QV Bioelectronics named as Regional Winners for the #North of England as part of the Super Connect for Good 2021! Thank you…
Read More
QV Bioelectronics Raises £735k for development of implanted electric field therapy device for brain cancer treatment.
£735k seed financing raised from VC and angel investors. The capital will be used to advance the development of the…
Read More@qvbio
March is Brain Tumor Awareness Month. Our startup is dedicated to innovation in this field, emphasising the critical need for community support and groundbreaking approaches. #BrainTumorAwareness
2
Our @AlderleyPark campus offers state-of-the-art labs where ideas can flourish. Just look at these pics of @qvbio’s new space!😍
💡Growing their business at #AlderleyPark, QV Bio is a start-up developing surgically implantable #medical devices to treat malignant brain tumours🔬
@InnovateUK & @UKinTX hosted @michelledonelan on her visit to @TXMedCenter to meet the latest cohort of UK-based #DigitalHealth & #Medical device startups participating in the TMC Innovation accelerator, part of Innovate UK's Global Incubator Programme.
⚕️https://ow.ly/5vwI50Q8EP1
Now Presenting: Christopher Bullock of @qvbio (Cheshire, UK). They are developing the world’s first implantable electric field therapy device to treat aggressive brain cancers.
Are you staying informed?
http://bit.ly/3G0kLGa
🎉Presenting in the #Oncology Therapeutic Category at Innovation Summit San Francisco 2023 is Presenting Company QV Bioelectronics (@qvbio) with CEO Christopher Bullock.
🎉 Welcome to #InnovationSF23, Chris and the QV Bioelectronics team! We are delighted to have you.